Plasmacytoid Urothelial Carcinoma of the Bladder That Manifests Disseminated Carcinomatosis of the Bone Marrow: A Case Report of Extremely Rapid Progression

Overview

Journal Case Rep Urol

Publisher Wiley

Specialty Urology

Date 2022 Sep 26

PMID 36157380

Authors

Nobuhiko Shimizu

Yoshinobu Moritoki

Nao Katsumi

Takahiro Yanase

Teruaki Sugino

Kazuhiro Kanemoto

Hidetoshi Akita

Takahiro Yasui

Affiliations

Soon will be listed here.

Abstract

Plasmacytoid urothelial carcinoma (PUC) of the bladder is a rare variant of invasive urothelial carcinoma (UC) with aggressive behavior. Despite its prognosis being poorer than that of conventional UC, a median overall survival of approximately 2 years is ensured when it is treated with radical cystectomy (RC), and few patients die within a few months of RC. In this paper, we report the case of a patient with PUC who developed widespread bone metastasis only 6 weeks after RC, which resulted in death within 2 months postoperatively.

Citing Articles

Differentiation Between Disseminated Carcinomatosis of the Bone Marrow From Urothelial Cancer and Intravascular Large B-cell Lymphoma: A Case Report.

Ohta R, Nishikura N, Suyama S, Sano C Cureus. 2024; 16(3):e57221.

PMID: 38686250 PMC: 11056314. DOI: 10.7759/cureus.57221.

An autopsy case of disseminated carcinomatosis of the bone marrow from esophageal adenocarcinoma.

Suzuki D, Meguro S, Furusawa S, Hashimoto N, Kawasaki H, Kosugi I Clin Case Rep. 2023; 11(9):e7877.

PMID: 37744630 PMC: 10511695. DOI: 10.1002/ccr3.7877.

References

Sood S, Paner G . Plasmacytoid Urothelial Carcinoma: An Unusual Variant That Warrants Aggressive Management and Critical Distinction on Transurethral Resections. Arch Pathol Lab Med. 2019; 143(12):1562-1567. DOI: 10.5858/arpa.2018-0139-RS. View

Erdemir F, Ozcan F, Kilicaslan I, Parlaktas B, Uluocak N, Gokce O . The relationship between the expression of E-cadherin and tumor recurrence and progression in high-grade stage T1 bladder urothelial carcinoma. Int Urol Nephrol. 2007; 39(4):1031-7. DOI: 10.1007/s11255-006-9159-5. View

Mir M, Marchioni M, Zargar H, Zargar-Shoshtari K, Fairey A, Mertens L . Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium. Eur Urol Focus. 2020; 7(6):1347-1354. DOI: 10.1016/j.euf.2020.07.002. View

Keck B, Wach S, Kunath F, Bertz S, Taubert H, Lehmann J . Nuclear E-cadherin expression is associated with the loss of membranous E-cadherin, plasmacytoid differentiation and reduced overall survival in urothelial carcinoma of the bladder. Ann Surg Oncol. 2012; 20(7):2440-5. DOI: 10.1245/s10434-012-2709-4. View

Keck B, Wach S, Stoehr R, Kunath F, Bertz S, Lehmann J . Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy. BMC Cancer. 2013; 13:71. PMC: 3572418. DOI: 10.1186/1471-2407-13-71. View

Iguchi H . Recent aspects for disseminated carcinomatosis of the bone marrow associated with gastric cancer: What has been done for the past, and what will be needed in future?. World J Gastroenterol. 2015; 21(43):12249-60. PMC: 4649110. DOI: 10.3748/wjg.v21.i43.12249. View

Veskimae E, Linares Espinos E, Bruins H, Yuan Y, Sylvester R, Kamat A . What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of.... Eur Urol Oncol. 2019; 2(6):625-642. DOI: 10.1016/j.euo.2019.09.003. View

Kohno M, Miyama K, Gohbara A, Onuki T, Sugiura S, Ikeda I . [DISSEMINATED CARCINOMATOSIS OF THE BONE MARROW WITH UROTHELIAL CARCINOMA]. Nihon Hinyokika Gakkai Zasshi. 2015; 106(2):114-7. DOI: 10.5980/jpnjurol.106.114. View

Leite K, Borges L, Filho L, Chade D, Coelho R, Cordeiro M . Histological Variants of Urothelial Carcinoma Predict No Response to Neoadjuvant Chemotherapy. Clin Genitourin Cancer. 2021; 20(1):e1-e6. DOI: 10.1016/j.clgc.2021.07.011. View

10.

Kim D, Kim J, Ro J, Lee H, Park J, Ahn H . Plasmacytoid Variant Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis of Clinicopathological Features and Survival Outcomes. J Urol. 2020; 204(2):215-223. DOI: 10.1097/JU.0000000000000794. View

11.

Mathieu R, Lucca I, Roupret M, Briganti A, Shariat S . The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder. Nat Rev Urol. 2016; 13(8):471-9. DOI: 10.1038/nrurol.2016.126. View